From Name:
From Email:
To Name:
To Email:

Optional Message:

Oncologists debate using maintenance bevacizumab in stage iiic ovarian cancer

from Cancer Therapy Advisor

In a recent paper published in the Journal of Clinical Oncology, the authors recommended using adjuvant and maintenance bevacizumab to treat a patient with stage IIIc ovarian cancer following an optimal (R0) resection. But in a letter to the editor, Ronald J. Buckanovich, M.D., Ph.D., a professor of medicine at the University of Pittsburgh, and colleagues disagreed with this suggestion, citing previous research on this issue and recommendations made by the American Society of Clinical Oncology Gynecologic Oncology Educational Committee. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063